Dec. 9, 2024 /PRNewswire/ -- PainTEQ, a leader in minimally invasive sacroiliac (SI) joint dysfunction treatment, has been awarded a new patent (US Patent No. 12,121,458), marking another ...
"LINQ's SI joint fusion is a significant advancement in our treatment of sacroiliac joint dysfunction, outpacing other lateral options on the market," said Dr. Sudir Diwan, Pain Management ...
New Patent Adds Significant Protections to PainTEQ's Instrumentation and Reinforces Its Leadership Position in Minimally Invasive SI Joint Dysfunction Treatment TAMPA, Fla., Dec. 9, 2024 /PRNewswire/ ...
PainTEQ has received a new US patent for its LinQ SI Joint Stabilization System aimed at alleviating sacroiliac (SI ... "PainTEQ's mission is to transform SI joint dysfunction treatment, and ...